The American Modern society of Clinical Oncology–Higher education of yankee Pathologists (ASCO–CAP) guidelines have ongoing to evolve to improve the accuracy and clinical utility of HER2 screening by giving specific algorithms15,16. In parallel with current strategies, novel methods to quantify HER2 degrees or standardize techniques are being